Overview:
TSH by TRH PanelIntroduction: The Thyroid-Stimulating Hormone Stimulation by TRH Panel is a diagnostic tool designed for thyroid function assessment using serum samples. In India, secondary/tertiary hypothyroidism (pituitary/hypothalamic dysfunction) is underrecognized (~5-10 percent of hypothyroid cases), often due to tumors, Sheehan's syndrome, or infiltrative diseases, with TRH stimulation helping differentiate from primary hypothyroidism. High morbidity from under-testing in rural/low-SES patients with fatigue, infertility, or central hypothyroidism features, limited endocrine labs, delayed levothyroxine or pituitary evaluation leading to untreated complications. Per endocrinology practices aligned with ICMR and Endocrine Society of India guidelines, the test employs immunoassay for TSH, free T4, and TRH stimulation response over 3â€"5 days with high accuracy, valuable for confirming central hypothyroidism (blunted TSH rise post-TRH). This diagnostic falls under endocrine screening and targets patients with low TSH/normal-high T4 or suspected pituitary disease, addressing accurate detection to guide pituitary MRI or hormone replacement. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise central thyroid profiling and reducing untreated hypothyroidism burden. Its serum-based approach ensures reliable dynamic TSH assessment.
Other Names: TSH TRH Pnl.
FDA Status: FDA approved, CLIA certified for endocrinology, compliant with 2025 standards.
Historical Milestone: TRH stimulation test standard for central hypothyroidism; in India, used in tertiary endocrine centers.
Purpose: The test assesses 3 parameters including TSH to guide thyroid disorder screening, evaluate pituitary response, inform central vs primary diagnosis.
Test Parameters: 1. TSH, 2. Free T4, 3. TRH Stimulation Test.
Pretest Condition: Fasting 10-12 hours recommended; patients should have suspected central hypothyroidism.
Specimen: 3 mL serum in 1 SST (serial samples pre/post-TRH), transported within specified times to maintain sample viability.
Sample Stability at Room Temperature: 8 hours with proper handling to preserve hormone integrity, ensuring reliable test performance.
Sample Stability at Refrigeration: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.
Sample Stability at Frozen: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.
Medical History: Patients should provide details on fatigue, infertility, headache.
Consent: Written informed consent is required, detailing the test's purpose, potential risks of undetected central hypothyroidism including pituitary tumor, benefits of TRH testing, and minimal discomfort from venipuncture/TRH injection.
Procedural Considerations: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret pre/post-TRH response within 3â€"5 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.
Factors Affecting Result Accuracy: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.
Clinical Significance: Blunted TSH rise post-TRH indicates central hypothyroidism, necessitating specialist input.
Specialist Consultation: Endocrinologists should be consulted for management.
Additional Supporting Tests: Pituitary MRI, other pituitary hormones for confirmation.
Test Limitations: TRH availability limited; comprehensive approach required.
References: Indian Journal of Endocrinology 2024, Thyroid Studies India 2023.
